COPD Trial, Recruiting (NCT06751537)

COPD Trial, Recruiting NCT06751537 Sponsor: LASARRUS Clinic and Research Center Condition: COPD

Printed from Voxsanity (voxsanity.com.au) — NCT06751537 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Copd

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults between the ages of 21 and 100, of any sex or racial/ethnic background, who are able to read and sign consent forms in English or Spanish.
People who have been diagnosed with COPD (a chronic lung condition that makes breathing difficult) according to internationally recognised standards, ranging from mild to very severe, confirmed through a breathing test called spirometry.
People whose COPD diagnosis appears in their medical records from within the past year.
Current smokers, former smokers, or people who have never smoked — any amount of time since quitting is acceptable.
People who are willing and able to take part in the study procedures required.

Who may not be able to join:

People with known skin allergies or skin conditions that could interfere with wearing a medical device on the skin.
People who are currently on invasive mechanical ventilation (a machine that breathes for them through a tube placed in the airway).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 301-388-5453

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06751537

Sponsor: LASARRUS Clinic and Research Center

Phase: Not Applicable

Status: Recruiting

Condition: COPD

Trial contact: 301-388-5453

More information: https://clinicaltrials.gov/study/NCT06751537

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults between the ages of 21 and 100, of any sex or racial/ethnic background, who are able to read and sign consent forms in English or Spanish.
People who have been diagnosed with COPD (a chronic lung condition that makes breathing difficult) according to internationally recognised standards, ranging from mild to very severe, confirmed through a breathing test called spirometry.
People whose COPD diagnosis appears in their medical records from within the past year.
Current smokers, former smokers, or people who have never smoked — any amount of time since quitting is acceptable.
People who are willing and able to take part in the study procedures required.

Who may not be able to join:

People with known skin allergies or skin conditions that could interfere with wearing a medical device on the skin.
People who are currently on invasive mechanical ventilation (a machine that breathes for them through a tube placed in the airway).

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

LASARRUS Clinic and Research Center

Registry

ClinicalTrials.gov

Start date

29 May 2025

Est. completion

31 January 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Agreement between WearME-Pro system and gold standard devices for FEV1 measurements, stratified by COPD severity.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov